Ragnhild Helseth

Publication Activity (10 Years)

Years Active: 2014-2022
Publications (10 Years): 9

Top Topics

St Segment Elevation Myocardial Infarction

Top Venues

Mediators of inflammation

Journal of immunology research

BMC cardiovascular disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Trine Baur Opstad, Jostein Nordeng, Alf-Aage R Pettersen, Sissel Åkra, Vibeke Bratseth, Hani Zaidi, Ragnhild Helseth, Svein Solheim, Ingebjørg Seljeflot
The NLRP3 Genetic Variant (rs10754555) Reduces the Risk of Adverse Outcome in Middle-Aged Patients with Chronic Coronary Syndrome. Journal of immunology research 2022 (2022)
Trine Baur Opstad, Jostein Nordeng, Alf-Aage R Pettersen, Sissel Åkra, Vibeke Bratseth, Hani Zaidi, Ragnhild Helseth, Svein Solheim, Ingebjørg Seljeflot
The NLRP3 Genetic Variant (rs10754555) Reduces the Risk of Adverse Outcome in Middle-Aged Patients with Chronic Coronary Syndrome. Journal of immunology research 2022 (2022)
Trine Baur Opstad, Jostein Nordeng, Alf-Aage R Pettersen, Sissel Åkra, Vibeke Bratseth, Hani Zaidi, Ragnhild Helseth, Svein Solheim, Ingebjørg Seljeflot
The NLRP3 Genetic Variant (rs10754555) Reduces the Risk of Adverse Outcome in Middle-Aged Patients with Chronic Coronary Syndrome. Journal of immunology research 2022 (2022)
Ragnhild Helseth, Ola Kleveland, Thor Ueland, Rune Wiseth, Jan Kristian Damas, Kaspar Broch, Annika Michelsen, Bjørn Bendz, Lars Gullestad, Pål Aukrust, Ingebjørg Seljeflot
Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction. Open heart 8 (1) (2021)
Jostein Nordeng, Hossein Schandiz, Svein Solheim, Sissel Åkra, Pavel Hoffmann, Borghild Roald, Bjørn Bendz, Harald Arnesen, Ragnhild Helseth, Ingebjørg Seljeflot
The Inflammasome Signaling Pathway Is Actively Regulated and Related to Myocardial Damage in Coronary Thrombi from Patients with STEMI. Mediators of inflammation 2021 (2021)
Karsten E Kluge, Miriam S Langseth, Trine Baur Opstad, Alf Å Pettersen, Harald Arnesen, Theis Tønnessen, Ingebjørg Seljeflot, Ragnhild Helseth
Complement Activation in Association with Markers of Neutrophil Extracellular Traps and Acute Myocardial Infarction in Stable Coronary Artery Disease. Mediators of inflammation 2020 (2020)
Ragnhild Helseth, Eva Cecilie Knudsen, Jan Eritsland, Trine Baur Opstad, Harald Arnesen, Geir Øystein Andersen, Ingebjørg Seljeflot
Glucose associated NETosis in patients with ST-elevation myocardial infarction: an observational study. BMC cardiovascular disorders 19 (1) (2019)
Ragnhild Helseth, Christian Shetelig, Geir Øystein Andersen, Miriam Sjåstad Langseth, Shanmuganathan Limalanathan, Trine B Opstad, Harald Arnesen, Pavel Hoffmann, Jan Eritsland, Ingebjørg Seljeflot
Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI. Mediators of inflammation 2019 (2019)
Ragnhild Helseth, Svein Solheim, Harald Arnesen, Ingebjørg Seljeflot, Trine Baur Opstad
The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris. Mediators of inflammation 2016 (2016)
Ragnhild Helseth, Svein Solheim, Trine Opstad, Pavel Hoffmann, Harald Arnesen, Ingebjørg Seljeflot
The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention. Mediators of inflammation 2014 (2014)